Task: Answer the multiple choice question.
Query: Which drug exhibits a -4.997% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCC(c1nnnn1Cc1ccccc1)N(Cc1cc2cc(OC)ccc2[nH]c1=O)CC1CCCO1
b. CCCCn1c(N)c(N(CC(C)C)C(=O)Cn2c(=O)cnc3ccccc32)c(=O)[nH]c1=O
c. O=C1C2C3c4ccccc4C(c4ccccc43)C2C(=O)N1c1cccnc1
Answer: c. O=C1C2C3c4ccccc4C(c4ccccc43)C2C(=O)N1c1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1C2C3c4ccccc4C(c4ccccc43)C2C(=O)N1c1cccnc1
O=C1C2C3c4ccccc4C(c4ccccc43)C2C(=O)N1c1cccnc1
17-pyridin-3-yl-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2(7),3,5,9(14),10,12-hexaene-16,18-dione